NOMD:NYSENomad Foods Limited Analysis
Data as of 2026-04-20 - not real-time
$9.67
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nomad Foods trades around $9.67, comfortably above its DCF-derived fair value of roughly $2.73, suggesting a significant premium. The stock sits beneath its 20‑day (≈9.70), 50‑day (≈10.69) and 200‑day (≈12.88) moving averages, with a 30‑day volatility of over 31% and a very low beta (~0.07), indicating high price swings but limited market‑wide correlation. Fundamentals show a modest 2.6% revenue contraction, thin profit margins (~4.5%) and a generous dividend yield of nearly 7% supported by a payout ratio of 66%, though free cash flow remains limited.
Management’s 2026 strategic plan emphasizes agility, cost efficiency and an aggressive share‑repurchase programme, while recent earnings beat expectations but missed revenue guidance, triggering a 6% price drop. The bearish technical backdrop, decreasing volume and a modestly bullish MACD histogram contrast with the high dividend appeal and undervalued book metrics, leaving investors weighing short‑term price weakness against long‑term value and income potential.
Management’s 2026 strategic plan emphasizes agility, cost efficiency and an aggressive share‑repurchase programme, while recent earnings beat expectations but missed revenue guidance, triggering a 6% price drop. The bearish technical backdrop, decreasing volume and a modestly bullish MACD histogram contrast with the high dividend appeal and undervalued book metrics, leaving investors weighing short‑term price weakness against long‑term value and income potential.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below all major moving averages indicating bearish momentum
- Decreasing volume and recent 6% drop after earnings miss
- Premium valuation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High dividend yield with a payout ratio below 70%
- Management’s share‑repurchase commitment supporting price support
- Revenue decline and margin pressure tempering upside
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong book value (P/B ~0.47) indicating deep value cushion
- Consumer‑defensive sector offering resilience in downturns
- Strategic focus on efficiency and agility that could stabilize earnings
Key Metrics & Analysis
Financial Health
Revenue Growth-2.60%
Profit Margin4.51%
P/E Ratio9.0
ROE5.30%
ROA4.01%
Debt/Equity91.77
P/B Ratio0.5
Op. Cash Flow$330.7M
Free Cash Flow$175.6M
Technical Analysis
TrendBearish
RSI41.0
Support$9.43
Resistance$10.02
MA 20$9.70
MA 50$10.69
MA 200$12.88
MACDBullish
VolumeDecreasing
Fear & Greed Index87.32
Valuation
Fair Value$2.73
GradeOvervalued
TypeValue
Dividend Yield6.98%
Risk Assessment
Beta0.07
Volatility31.79%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.